Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants

Abstract

Background:

Antenal indomethacin reportedly decreases the responses of a symptomatic patent ductus arteriosus (sPDA) to postnatal indomethacin treatment. Whether a similar exposure affects the responses to indomethacin prophylaxis is unknown.

Objective:

To evaluate the clinical responsiveness of ductus arteriosus to indomethacin prophylaxis and to the treatment of sPDA in extremely low birth weight (ELBW) infants following indomethacin tocolysis.

Methods:

Retrospective cohort study of 58 ELBW infants whose mothers received indomethacin tocolysis (study) and 58 ELBW infants whose mothers did not (controls), matched by gender, gestational age (GA), birth weight and postnatal sPDA management (prophylaxis or early treatment).

Results:

Indomethacin was used as a tocolytic at a median dose of 250 mg, for a duration of 2 days, and ending 1 day before delivery. Study and control mothers were comparable in demographics, antenatal steroid use, cesarean delivery, but were different in the incidence of preeclampsia and preterm labor. Study and control infants were similar in birth weight, GA, indomethacin prophylaxis, early sPDA treatment, mortality, necrotizing enterocolitis, severe intraventricular hemorrhage and stage 3–5 retinopathy of prematurity. Seventeen of 43 study and 16 of 43 control infants who received indomethacin prophylaxis developed sPDA and were combined with early treatment sPDA infants (15 to each group). Two of 32 study and two of 31 control infants underwent surgical ligation whereas the remaining were treated with indomethacin. Sixteen of 30 (53%) and 13 of 29 (45%) were successfully treated and did not require ligation. Study infants were divided according to their mothers' indomethacin total dose (28 infants received 225 mg and 30 infants received >225 mg). Both subgroups were demographically and clinically comparable and their response to indomethacin prophylaxis and treatment were similar.

Conclusion:

In ELBW infants, exposure to indomethacin tocolysis does not affect the clinical responsiveness of the ductus arteriosus to prophylaxis or that of the sPDA to indomethacin treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hermes-DeSantis ER, Clyman RI . Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26: S14–S18.

    Article  PubMed  Google Scholar 

  2. Clyman RI . Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996; 128: 601–607.

    Article  CAS  PubMed  Google Scholar 

  3. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR . Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113–1121.

    Article  PubMed  Google Scholar 

  4. Schmidt B, Davis P, Modemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.

    Article  CAS  PubMed  Google Scholar 

  5. Fowlie PW, Davis PG . Prophylactic indomethacin for preterm infants; a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F464–F466.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Narayanan M, Cooper B, Weiss H, Clyman RI . Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000; 136: 330–337.

    Article  CAS  PubMed  Google Scholar 

  7. Norton M, Merrill J, Cooper B, Kuller J, Clyman R . Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602–1607.

    Article  CAS  PubMed  Google Scholar 

  8. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H . Antenatal indomethacin – adverse fetal effects confirmed. Aust NZ J Obstet Gynaecol 1998; 38: 11–16.

    Article  CAS  Google Scholar 

  9. Hammerman C, Glaser J, Kaplan M, Schimmel M, Ferber B, Eidelman A . Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998; 102: 1–4.

    Article  Google Scholar 

  10. Suarez VR, Thompson LL, Jain V, Olson GL, Hankins GDV, Belfort MA et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol 2002; 187: 886–888.

    Article  CAS  PubMed  Google Scholar 

  11. Vermillion ST, Landen CN . Prostaglandin inhibitors as tocolytic agents. Semin Perinatol 2001; 25: 256–262.

    Article  CAS  PubMed  Google Scholar 

  12. Iams JD, Creasy RK . Preterm labor and delivery In: Creasy RJ, Resnik R, Iams JD (eds). Maternal-Fetal Medicine: Principles and Practice. 5th edn Saunders: Philadelphia, PA, 2004, p 623–651.

    Google Scholar 

  13. Loe S, Sanchez-Ramos L, Kaunitz A . Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005; 106: 173–179.

    Article  PubMed  Google Scholar 

  14. Van Den Veyver IB, Moise KJ, Ou C, Carpenter RJ . The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 1993; 82: 500–503.

    CAS  PubMed  Google Scholar 

  15. Vermillion S, Scardo J, Lashus A, Wiles H . The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177: 256–261.

    Article  CAS  PubMed  Google Scholar 

  16. Abbasi S, Gerdes JS, Sehdev HM, Samimi SS, Ludmir J . Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol 2003; 189: 782–785.

    Article  CAS  PubMed  Google Scholar 

  17. Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with weights less than 1500 g. J Pediatr 1978; 92: 529–534.

    Article  CAS  PubMed  Google Scholar 

  18. Macones GA, Marder SJ, Clothier B, Stamilio DM . The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001; 184: 264–272.

    Article  CAS  PubMed  Google Scholar 

  19. Ojala R, Ikonen S, Tammela O . Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 2000; 159: 153–155.

    Article  CAS  PubMed  Google Scholar 

  20. Gardner MO, Owen J, Skelly S, Hauth JC . Preterm delivery after indomethacin: a risk factor for neonatal complications? J Reprod Med 1996; 41: 903–906.

    CAS  PubMed  Google Scholar 

  21. Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA . Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol 2005; 25: 336–340.

    Article  CAS  PubMed  Google Scholar 

  22. Tyson JE, Younes J, Verter J, Wright LL . Viability, morbidity, and resource use among newborns of 501–800 g birth weight. JAMA 1996; 276: 1645–1651.

    Article  CAS  PubMed  Google Scholar 

  23. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26: 93–99.

    Article  CAS  PubMed  Google Scholar 

  24. Clyman RI, Chen YQ, Chemtob S, Mauray F, Kohl T, Varma DR et al. In utero remodeling of the fetal lamb ductus arteriosus: the role of antenatal indomethacin and a vascular zone thickness on vasa basorum proliferation, neointima formation, and cell death. Circulation 2001; 103: 1806–1812.

    Article  CAS  PubMed  Google Scholar 

  25. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia and gestation. Pediatr Res 1999; 45: 19–29.

    Article  CAS  PubMed  Google Scholar 

  26. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R . Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 1995; 127: 466–471.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Cordero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cordero, L., Nankervis, C., Gardner, D. et al. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 27, 22–27 (2007). https://doi.org/10.1038/sj.jp.7211612

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211612

Keywords

This article is cited by

Search

Quick links